30 Oct 2015
Enquiry// Oncology products required by R&D facility in Vietnam [EN00149-EN00150-EN00151-EN00152-EN-00153-EN00154-EN00155]
U.S. based AMPHARCO USA has set up a dedicated R&D facility for oncology products in Vietnam. Manufacturers in a position to supply the following products should contact them directly.
CEP Grade Required - CARBOPLATIN, CISPLATIN, DOCETAXEL ANHYDROUS, GEMICITABINE HCL, OXALIPLATIN
Other Requirements - TEMOZOLAMIDE, THALIDOMIDE
AMPHARCOUSA requires COA and stability data for initial vendor assessment purposes.
CEP Grade Required - CARBOPLATIN, CISPLATIN, DOCETAXEL ANHYDROUS, GEMICITABINE HCL, OXALIPLATIN
Other Requirements - TEMOZOLAMIDE, THALIDOMIDE
AMPHARCOUSA requires COA and stability data for initial vendor assessment purposes.
yazdanif@cinnagen.com
Dear sir,
If you are still interested we can supply.
Please feel free to contact me: yazdanif@cinnagen.com
20:57, 18 Jul 2018